Images List Premium Download Classic

Immune Disorder

Immune Disorder-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
Novo Nordisk A/s
November 09, 2017 - N°20170320946

Novel activating receptors of the ig super-family expressed on human myeloid cells, called trem(s) (triggering receptor expressed on myeloid cells) are provided. Specifically, two (2) members of trems, trem-1 and trem-2 are disclosed. Trem-1 is a transmembrane glycoprotein expressed selectively on blood neutrophils and a subset of monocytes but not on lymphocytes and other cell types and is upregulated by ...
Cytokine-based fusion proteins for treatment of immune disorders
East Carolina University
November 09, 2017 - N°20170320933

The present invention provides fusion proteins including an autoimmune antigen, an allergen antigen or an alloantigen, and an anti-inflammatory cytokine. Compositions and methods including the fusion proteins are also provided.
Method for treating inflammatory disorders
Synta Pharmaceuticals Corp.
November 09, 2017 - N°20170320837

The present invention relates to a method for suppressing the immune system in a subject in need thereof, and a method for treating an inflammatory or immune disorder in a subject in need thereof.
Immune Disorder Patent Pack
Download 119+ patent application PDFs
Immune Disorder Patent Applications
Download 119+ Immune Disorder-related PDFs
For professional research & prior art discovery
inventor
  • 119+ full patent PDF documents of Immune Disorder-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
Biosuccess Biotech Co. Ltd.
November 02, 2017 - N°20170316169

A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune ...
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
Biosuccess Biotech Co. Ltd.
November 02, 2017 - N°20170316168

A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune ...
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
Biosuccess Biotech Co. Ltd.
November 02, 2017 - N°20170316167

A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune ...
Immune Disorder Patent Pack
Download 119+ patent application PDFs
Immune Disorder Patent Applications
Download 119+ Immune Disorder-related PDFs
For professional research & prior art discovery
inventor
  • 119+ full patent PDF documents of Immune Disorder-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Detection of an immune response
Biosuccess Biotech Co. Ltd.
November 02, 2017 - N°20170315123

Provided herein are methods of detecting and/or monitoring the presence or severity of an immune disorder in a subject, including detecting a frequency of a th2a subset of cd4+ t cells in a biological sample of the subject. In some embodiments, the detecting includes: (a) detecting a frequency of cd4+ t cells in a biological sample of said ...
Methods of treating graft versus host disease using il-2 muteins
Biosuccess Biotech Co. Ltd.
November 02, 2017 - N°20170313753

Described herein are immunosuppressive molecules including immunosuppressive variants of il-2, and use of such molecules to treat inflammatory and autoimmune disorders.
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of rorgamma activity and the treatment of disease
Biosuccess Biotech Co. Ltd.
November 02, 2017 - N°20170313722

The invention provides tetrahydronaphthyridine and related compounds, pharmaceutical compositions, methods of inhibiting rorγ activity, reducing the amount of il-17 in a subject, and treating immune disorders and inflammatory disorders using such tetrahydronaphthyridine and related compounds.
Cytokines and neuroantigens for treatment of immune disorders
Biosuccess Biotech Co. Ltd.
November 02, 2017 - N°20170312358

The present invention provides methods of regulating an immunological disorder comprising administering to a subject an effective amount of (i) an autoimmune antigen in conjunction with (ii) an anti-inflammatory cytokine. Compositions including the same are also provided.
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
Ubiome, Inc.
October 26, 2017 - N°20170308660

A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune ...
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
Ubiome, Inc.
October 26, 2017 - N°20170308659

A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune ...
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
Ubiome, Inc.
October 26, 2017 - N°20170308658

A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune ...
Immune Disorder Patent Pack
Download 119+ patent application PDFs
Immune Disorder Patent Applications
Download 119+ Immune Disorder-related PDFs
For professional research & prior art discovery
inventor
  • 119+ full patent PDF documents of Immune Disorder-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Use of levocetirizine and montelukast in the treatment of autoimmune disorders
Ubiome, Inc.
October 19, 2017 - N°20170296534

The embodiments described herein include methods and formulations for treating autoimmune disorders. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
Cancer treatment and immune system regulation through fat10 pathway inhibition
President And Fellows Of Harvard College
September 28, 2017 - N°20170275623

Described herein are methods of inhibiting mitosis, treating cancer and/or treating immune disorders through the use of agents that inhibit fat10 and/or the fat10 pathway.
Multivalent cd20-binding molecule comprising shiga toxin a subunit effector polypeptides and enriched compositions therefof
Molecular Templates, Inc.
September 28, 2017 - N°20170275382

The present invention provides multivalent cd20-binding molecules, and compositions thereof, such as enriched compositions comprising large proportions of multivalent cd20-binding molecule relative to monovalent cd20-binding molecule. Certain multivalent cd20-binding molecules of the present invention comprise 1) two or more cd20 binding regions and 2) one or more shiga toxin effector polypeptide regions derived from an a subunit of ...
Polypeptides and uses thereof as a drug for treatment of autoimmune disorders
Compugen Ltd.
September 28, 2017 - N°20170275344

This invention, in at least some embodiments, relates to a protein c1orf32 and its variants and fragments and fusion proteins thereof, and methods of use thereof for immunotherapy, and drug development, including but not limited to as immune modulators and for immune therapy, including for autoimmune disorders.
Modulators of retinoid-related orphan receptor gamma
Orphagen Pharmaceuticals, Inc.
September 21, 2017 - N°20170267712

Methods for modulating (inhibiting or stimulating) retinoid-related orphan receptor γ (rorγ) activity. This modulation has numerous effects, including inhibition of th-17 cell function and/or th-17 cell activity, and inhibition of re-stimulation of th-17 cells, which are beneficial to treatment of inflammation and autoimmune disorders. Stimulation of rorγ results in stimulation of th-17 cell function ...
Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
Lycera Corporation
September 21, 2017 - N°20170267643

The invention provides pyrazolyl guanidine compounds that inhibit f1fo-atpase, and methods of using pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
Treatment of t-cell mediated immune disorders
Mesoblast, Inc.
September 14, 2017 - N°20170258846

A method for suppressing t cell activation which comprises contacting a cell population comprising t cells in vitro or ex vivo with an effective amount of stro-1+ cells and/or soluble factors derived therefrom to suppress t cell activation.
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
Incyte Holdings Corporation
September 07, 2017 - N°20170253598

The present invention provides azetidinyl phenyl, pyridyl, or pyrazinyl carboxamide derivatives, as well as their compositions and methods of use, that modulate the activity of janus kinase (jaks) and are useful in the treatment of diseases related to the activity of jak including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
Loading